ArticlePloS one2022

Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet.

PLOS ONE EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.